Cbl-b silenced human NK cells respond stronger to cytokine stimulation

Yazar: Lametschwandtner, Guenther, Sachet, Monika, Haslinger, Isabella, Mühleisen, Hannes, Loibner, Hans
Yayımlandı J Immunother Cancer (2015)

Phase I clinical trial of adoptive cellular immunotherapy with APN401 in patients with solid tumors

Yazar: Triozzi, Pierre, Kooshki, Mitra, Alistar, Angela, Bitting, Rhonda, Neal, Amy, Lametschwandtner, Guenther, Loibner, Hans
Yayımlandı J Immunother Cancer (2015)

Treatment of a cancer patient by an adoptive cell therapy protocol combining DC vaccination with cbl-b ex vivo silencing

Yazar: Sachet, Monika, Lametschwandtner, Guenther, Hayden, Hubert, Hassler, Michaela, Loibner, Hans, Triozzi, Pierre, Friedl, Josef
Yayımlandı J Immunother Cancer (2015)

Overcoming immune-cell unresponsiveness in cancer

Yazar: Lametschwandtner, Guenther, Ermann, Monika, Sternberger, Ina, Hesterkamp, Thomas, Haslinger, Isabella, Mühleisen, Hannes, Schuster, Manfred, Loibner, Hans
Baskı/Yayın Bilgisi 2013

Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients

Yazar: Lode, Holger, Siebert, Nikolai, Kietz, Silke, Müller, Ina, Schuster, Manfred, Janzek, Evelyne, Wiederkum, Susanne, Mutschlechner, Oliver, Loibner, Hans
Baskı/Yayın Bilgisi 2013

Development of a personalized cellular ex-vivo cbl-b silencing cancer immunotherapy

Yazar: Lametschwandtner, Guenther, Loibner, Hans, Sachet, Monika, Hayden, Hubert, Hassler, Michaela, Schuster, Manfred, Salzberg, Marc, Triozzi, Pierre, Friedl, Josef
Yayımlandı J Immunother Cancer (2014)

Recombinant Expression and Characterization of Human and Murine ACE2: Species-Specific Activation of the Alternative Renin-Angiotensin-System

Yazar: Poglitsch, Marko, Domenig, Oliver, Schwager, Cornelia, Stranner, Stefan, Peball, Bernhard, Janzek, Evelyne, Wagner, Bettina, Jungwirth, Helmut, Loibner, Hans, Schuster, Manfred
Baskı/Yayın Bilgisi 2012

Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combin...

Yazar: Troschke-Meurer, Sascha, Siebert, Nikolai, Marx, Madlen, Zumpe, Maxi, Ehlert, Karoline, Mutschlechner, Oliver, Loibner, Hans, Ladenstein, Ruth, Lode, Holger N.
Yayımlandı Oncoimmunology (2019)

Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy

Yazar: Suppan, Christoph, Bjelic-Radisic, Vesna, La Garde, Marlen, Groselj-Strele, Andrea, Eberhard, Katharina, Samonigg, Hellmut, Loibner, Hans, Dandachi, Nadia, Balic, Marija
Yayımlandı BMC Cancer (2015)

Charge heterogeneity: Basic antibody charge variants with increased binding to Fc receptors

Yazar: Hintersteiner, Beate, Lingg, Nico, Zhang, Peiqing, Woen, Susanto, Hoi, Kong Meng, Stranner, Stefan, Wiederkum, Susanne, Mutschlechner, Oliver, Schuster, Manfred, Loibner, Hans, Jungbauer, Alois
Yayımlandı MAbs (2016)

Adoptive Transfer of siRNA Cblb-Silenced CD8(+) T Lymphocytes Augments Tumor Vaccine Efficacy in a B16 Melanoma Model

Yazar: Hinterleitner, Reinhard, Gruber, Thomas, Pfeifhofer-Obermair, Christa, Lutz-Nicoladoni, Christina, Tzankov, Alexander, Schuster, Manfred, Penninger, Josef M., Loibner, Hans, Lametschwandtner, Günther, Wolf, Dominik, Baier, Gottfried
Baskı/Yayın Bilgisi 2012

Targeting the Degradation of Angiotensin II with Recombinant ACE2: Prevention of Angiotensin II-dependent Hypertension

Yazar: Wysocki, Jan, Ye, Minghao, Rodriguez, Eva, González-Pacheco, Francisco R., Barrios, Clara, Evora, Karla, Schuster, Manfred, Loibner, Hans, Brosnihan, K. Bridget, Ferrario, Carlos M., Penninger, Josef M., Batlle, Daniel
Baskı/Yayın Bilgisi 2009

Effective combination of innate and adaptive immunotherapeutic approaches in a mouse melanoma model

Yazar: Rakhmilevich, Alexander L., Felder, Mildred, Lever, Lauren, Slowinski, Jacob, Rasmussen, Kayla, Hoefges, Anna, Van De Voort, Tyler J., Loibner, Hans, Korman, Alan J., Gillies, Stephen D., Sondel, Paul M.
Yayımlandı J Immunol (2017)

Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2

Yazar: Siebert, Nikolai, Eger, Christin, Seidel, Diana, Jüttner, Madlen, Zumpe, Maxi, Wegner, Danilo, Kietz, Silke, Ehlert, Karoline, Veal, Gareth J., Siegmund, Werner, Weiss, Michael, Loibner, Hans, Ladenstein, Ruth, Lode, Holger N.
Yayımlandı MAbs (2016)

Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy

Yazar: Oudit, Gavin Y., Liu, George C., Zhong, JiuChang, Basu, Ratnadeep, Chow, Fung L., Zhou, Joyce, Loibner, Hans, Janzek, Evelyne, Schuster, Manfred, Penninger, Josef M., Herzenberg, Andrew M., Kassiri, Zamaneh, Scholey, James W.
Baskı/Yayın Bilgisi 2010

Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 Trial

Yazar: Siebert, Nikolai, Troschke-Meurer, Sascha, Marx, Madlen, Zumpe, Maxi, Ehlert, Karoline, Gray, Juliet, Garaventa, Alberto, Manzitti, Carla, Ash, Shifra, Klingebiel, Thomas, Beck, James, Castel, Victoria, Valteau-Couanet, Dominique, Loibner, Hans, Ladenstein, Ruth, Lode, Holger N.
Yayımlandı Cancers (Basel) (2018)

Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD(2) antibody ch14.18/CHO

Yazar: Mueller, Ina, Ehlert, Karoline, Endres, Stefanie, Pill, Lena, Siebert, Nikolai, Kietz, Silke, Brock, Penelope, Garaventa, Alberto, Valteau-Couanet, Dominique, Janzek, Evelyne, Hosten, Norbert, Zinke, Andreas, Barthlen, Winfried, Varol, Emine, Loibner, Hans, Ladenstein, Ruth, Lode, Holger N.
Yayımlandı MAbs (2017)

Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension

Yazar: Johnson, Jennifer A., Hemnes, Anna R., Perrien, Daniel S., Schuster, Manfred, Robinson, Linda J., Gladson, Santhi, Loibner, Hans, Bai, Susan, Blackwell, Tom R., Tada, Yuji, Harral, Julie W., Talati, Megha, Lane, Kirk B., Fagan, Karen A., West, James
Baskı/Yayın Bilgisi 2012

Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma

Yazar: Albertini, Mark R., Yang, Richard K., Ranheim, Erik A., Hank, Jacquelyn A., Zuleger, Cindy L., Weber, Sharon, Neuman, Heather, Hartig, Greg, Weigel, Tracey, Mahvi, David, Henry, Mary Beth, Quale, Renae, McFarland, Thomas, Gan, Jacek, Carmichael, Lakeesha, Kim, KyungMann, Loibner, Hans, Gillies, Stephen D., Sondel, Paul M.
Yayımlandı Cancer Immunol Immunother (2018)

Tumor-specific inhibition of in situ vaccination by distant untreated tumor sites

Yazar: Morris, Zachary S., Guy, Emily I., Werner, Lauryn R., Carlson, Peter M., Heinze, Clinton M., Kler, Jasdeep S., Busche, Sara M., Jaquish, Abigail A., Sriramaneni, Raghava N., Carmichael, Lakeesha L., Loibner, Hans, Gillies, Stephen D., Korman, Alan J., Erbe, Amy K., Hank, Jacquelyn A., Rakhmilevich, Alexander L., Harari, Paul M., Sondel, Paul M.
Yayımlandı Cancer Immunol Res (2018)